Medicine and Dentistry
Cardiovascular Disease
100%
Cohort Analysis
66%
Diagnosis
56%
Maturity Onset Diabetes of the Young
52%
Polycystic Ovary Syndrome
49%
Osteoprotegerin
49%
Prevalence
47%
Anemia
43%
Thrombocyte Function
43%
Platelet
43%
Lung Cancer
42%
Systematic Review
41%
Lobectomy
39%
Partial Thromboplastin Time
36%
C Reactive Protein
36%
Chronic Kidney Disease
35%
Diabetes Mellitus
35%
Atrial Fibrillation
35%
Venous Thromboembolism
34%
Thrombocyte Aggregation
34%
Malignant Neoplasm
33%
Brain Natriuretic Peptide
32%
Randomized Controlled Trial
32%
Video-Assisted Thoracoscopic Surgery
31%
Centenarians
29%
Thrombocytopenia
29%
Laboratory Test
28%
Laboratory Medicine
28%
Diabetes
27%
Blood Clotting
27%
Venous Blood
27%
Thromboembolism
27%
Pre-Analytical Phase
26%
Biological Marker
25%
Troponin I
24%
Insulin Dependent Diabetes Mellitus
24%
Von Willebrand Factor
24%
Apoplexy
24%
Disease
22%
D-Dimer
22%
Fragility Fracture
21%
Heart Failure
21%
Awareness
20%
Blood Gas
20%
Hemoglobin Determination
20%
Cardiovascular System
19%
Bone Density
19%
Bisphosphonate
19%
Immigrant Woman
19%
Clinician
19%
Biochemistry, Genetics and Molecular Biology
Pre-Analytical Phase
94%
Clinical Biochemistry
90%
Blood Level
54%
Cohort Study
52%
Lipid
42%
Prevalence
42%
Thrombocyte Aggregation
42%
Cardiac Troponin
41%
Blood Sampling
40%
Bone Density
39%
Osteoprotegerin
39%
Thrombocyte Activation
37%
Troponin I
34%
Low-Density Lipoprotein
33%
Troponin
33%
Dyslipidemia
30%
Phlebothrombosis
29%
Laboratory Test
27%
Glycated Hemoglobin
25%
Triglyceride
25%
Atrial Fibrillation
25%
Fibrinogen
25%
D-Dimer
24%
Glucose Blood Level
24%
Quality Control
24%
Thrombophilia
24%
Platelet
23%
Population
23%
Creatinine
21%
Thrombocyte Function
21%
Von Willebrand Factor
21%
Calgranulin
19%
Hemodialysis
19%
Diacylglycerol Lipase
19%
Denaturing High Performance Liquid Chromatography
19%
Exon
18%
Body Mass
17%
Kidney Function
16%
Partial Thromboplastin Time
16%
Thrombin
16%
Hemostasis
15%
Solution and Solubility
15%
Brain Natriuretic Peptide
14%
Fibroblast Growth Factor 23
14%
Platelet Count
14%
Insulin Resistance
14%
Reference Value
13%
Randomized Controlled Trial
13%
Centrifugation
13%
Risk Reduction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Osteoprotegerin
69%
Chronic Kidney Failure
55%
Cohort Study
49%
Randomized Controlled Trial
45%
Prevalence
44%
Cardiovascular Disease
39%
Brain Natriuretic Peptide
39%
Non Insulin Dependent Diabetes Mellitus
39%
Anemia
36%
Diabetes Mellitus
35%
Von Willebrand Factor
34%
Atrial Fibrillation
32%
Dabigatran
29%
Fragility Fracture
26%
Biological Marker
25%
Placebo
24%
Acute Coronary Syndrome
22%
C Reactive Protein
22%
Heart Failure
21%
Serum Amyloid P
21%
Bisphosphonic Acid Derivative
21%
Creatinine
21%
Hyperinsulinemia
20%
Idarucizumab
19%
Amyloid Protein
19%
Lipoprotein
19%
Ovary Polycystic Disease
19%
D Dimer
18%
Alendronic Acid
18%
Liver Cirrhosis
17%
Fibrinogen
17%
Hemodialysis
17%
Thrombin
16%
Thromboplastin
16%
Cardiovascular Risk
16%
Symptom
15%
Venous Thromboembolism
15%
Malignant Neoplasm
15%
Troponin I
14%
Blood Stasis
14%
Kidney Disease
14%
Low Density Lipoprotein Cholesterol
14%
Coronary Artery Disease
13%
Peripheral Occlusive Artery Disease
13%
Disease
13%
Enzyme-Linked Immunosorbent Assay
13%
Bleeding
13%
Case-Control Study
13%
Atherosclerosis
13%
Hip Fracture
12%
